ASX
Mesoblast Limited
MSB:ASX•Healthcare
Sensitive ASX Announcement
DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
Published: 11/11/20, 10:11am (AEST)•3 pages